TransDigm Group Work in process increased by 5.9% to $681.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.0%, from $528.00M to $681.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 8.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $347.00M | $322.00M | $335.00M | $357.00M | $369.00M | $359.00M | $390.00M | $427.00M | $453.00M | $455.00M | $480.00M | $512.00M | $508.00M | $508.00M | $500.00M | $528.00M | $542.00M | $543.00M | $643.00M | $681.00M |
| QoQ Change | — | -7.2% | +4.0% | +6.6% | +3.4% | -2.7% | +8.6% | +9.5% | +6.1% | +0.4% | +5.5% | +6.7% | -0.8% | +0.0% | -1.6% | +5.6% | +2.7% | +0.2% | +18.4% | +5.9% |
| YoY Change | — | — | — | — | +6.3% | +11.5% | +16.4% | +19.6% | +22.8% | +26.7% | +23.1% | +19.9% | +12.1% | +11.6% | +4.2% | +3.1% | +6.7% | +6.9% | +28.6% | +29.0% |
| % of Inventories | 24.4% | 23.4% | 23.7% | 24.8% | 24.3% | 23.5% | 23.7% | 24.6% | 25.0% | 24.9% | 25.0% | 25.9% | 24.1% | 24.1% | 23.1% | 23.4% | 23.1% | 25.9% | 27.1% | 28.4% |
| Share Change | — | -1.1pp | +0.4pp | +1.1pp | -0.5pp | -0.8pp | +0.2pp | +0.9pp | +0.4pp | -0.0pp | +0.0pp | +1.0pp | -1.8pp | -0.1pp | -1.0pp | +0.3pp | -0.3pp | +2.8pp | +1.2pp | +1.3pp |